Dorsey Wright & Associates Buys 20,914 Shares of The Ensign Group, Inc. $ENSG

Dorsey Wright & Associates boosted its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 66.7% during the first quarter, Holdings Channel reports. The institutional investor owned 52,247 shares of the company’s stock after buying an additional 20,914 shares during the period. The Ensign Group comprises approximately 1.3% of Dorsey Wright & Associates’ investment portfolio, making the stock its 23rd biggest position. Dorsey Wright & Associates’ holdings in The Ensign Group were worth $10,528,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Baillie Gifford & Co. lifted its position in The Ensign Group by 62.1% during the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after acquiring an additional 1,750,645 shares during the last quarter. Wasatch Advisors LP grew its position in shares of The Ensign Group by 6.0% in the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of The Ensign Group by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock worth $261,107,000 after purchasing an additional 49,117 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of The Ensign Group by 9.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after purchasing an additional 118,110 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in The Ensign Group by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company’s stock worth $190,033,000 after purchasing an additional 5,458 shares during the last quarter. 96.12% of the stock is owned by institutional investors.

Insider Buying and Selling at The Ensign Group

In related news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director owned 21,352 shares in the company, valued at $3,507,706.56. The trade was a 3.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $199.97, for a total value of $78,388.24. Following the completion of the transaction, the director directly owned 9,295 shares of the company’s stock, valued at approximately $1,858,721.15. The trade was a 4.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,792 shares of company stock valued at $320,931 over the last quarter. Company insiders own 4.00% of the company’s stock.

The Ensign Group Trading Down 0.9%

Shares of ENSG opened at $171.28 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The Ensign Group, Inc. has a 52-week low of $134.79 and a 52-week high of $218.00. The firm has a market cap of $10.01 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 1.69 and a beta of 0.69. The business’s fifty day moving average is $165.85 and its 200-day moving average is $184.01.

The Ensign Group (NASDAQ:ENSG) last posted its earnings results on Thursday, April 30th. The company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.79 by $0.06. The firm had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Equities analysts anticipate that The Ensign Group, Inc. will post 6.82 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.23%.

Analyst Ratings Changes

ENSG has been the topic of several recent research reports. Truist Financial lowered their price objective on The Ensign Group from $215.00 to $202.00 and set a “hold” rating on the stock in a research report on Tuesday. Zacks Research downgraded shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Weiss Ratings cut shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of The Ensign Group in a report on Tuesday, June 9th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, The Ensign Group has a consensus rating of “Moderate Buy” and an average price target of $213.50.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.